Genotoxicity of ibuprofen in mouse bone marrow cells in vivo

Genotoxicity of ibuprofen was evaluated by employing the mouse in vivo chromosomal aberration (CA) test. Ibuprofen administered orally at doses of 10, 20, 40, and 60 mg/kg body weight to mice resulted in mitotic depression and induction of CAs. A dose-related decrease in mitotic index (MI) and an increase in the frequencies of chromosomal aberrations per cell (CAs/cell) were recorded in bone marrow cells. However, a statistically significant reduction in MI and an increase in CAs/cell were found for both the higher doses. The results obtained indicate that ibuprofen is capable of inducing dose-dependent genotoxicity in bone marrow cells of mice.

[1]  Howard I. Maibach,et al.  OECD GUIDELINES FOR THE TESTING OF CHEMICALS In Vitro Skin Corrosion: Transcutaneous Electrical Resistance Test Method , 2013 .

[2]  M. Ghosh,et al.  High-altitude medicines: A short-term genotoxicity study , 2010, Toxicology and industrial health.

[3]  F. Huq.  Molecular Modelling Analysis of the Metabolism of Ibuprofen , 2006 .

[4]  G. Salles,et al.  The superoxide dismutase content in erythrocytes predicts short‐term toxicity of high‐dose cyclophosphamide , 2001, British journal of haematology.

[5]  S. B. Prasad,et al.  Vitamin C mediated protection on cisplatin induced mutagenicity in mice. , 1998, Mutation research.

[6]  A. Giri,et al.  Comparative mutagenic and genotoxic effects of three propionic acid derivatives ibuprofen, ketoprofen and naproxen. , 1997, Mutation research.

[7]  S D Hall,et al.  Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. , 1997, Biochemical pharmacology.

[8]  S. Mashiko,et al.  Participation of reactive oxygen species in phototoxicity induced by quinolone antibacterial agents. , 1997, Archives of biochemistry and biophysics.

[9]  A. P. Odin.  Vitamins as antimutagens: advantages and some possible mechanisms of antimutagenic action. , 1997, Mutation research.

[10]  G. Lóarca-Piña,et al.  Antimutagenic activity of natural xanthophylls against aflatoxin B1 in Salmonella typhimurium , 1997, Environmental and molecular mutagenesis.

[11]  A. Bishayee,et al.  Beta-carotene inhibits rat liver chromosomal aberrations and DNA chain break after a single injection of diethylnitrosamine. , 1997, British Journal of Cancer.

[12]  M. Waters,et al.  Genetic activity profiles of anticancer drugs. , 1996, Mutation research.

[13]  J. Anderson,et al.  Use of cyclophosphamide as a positive control in dominant lethal and micronucleus assays. , 1995, Mutation research.

[14]  R. C. Garner,et al.  Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. , 1995, Mutation research.

[15]  Y. Tsai,et al.  Ibuprofen overdose complicated by renal failure, adult respiratory distress syndrome, and metabolic acidosis. , 1994, Journal of toxicology. Clinical toxicology.

[16]  A. Knaap,et al.  Role of genotoxicity assays in the regulation of chemicals in The Netherlands: considerations and experiences. , 1991, Mutagenesis.

[17]  P. Dennis.  Environmental Health Criteria 75 , 1989 .

[18]  M. Shelby,et al.  Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells. , 1987, Mutation research.

[19]  R. Baker.  Environment Health Criteria 51 — Guide to Short-Term Tests for Detecting Mutagenic and Carcinogenic Chemicals , 1987 .

[20]  C. A. Luke,et al.  Methyl isocyanate: an evaluation of in vivo cytogenetic activity. , 1987, Environmental mutagenesis.

[21]  J. Paulson,et al.  Mutagenicity testing of selected analgesics in Ames Salmonella strains , 1986, Journal of applied toxicology : JAT.

[22]  G. Klein,et al.  Investigations of the influence of nonsteroidal antirheumatic drugs on the rates of sister-chromatid exchange. , 1986, Mutation research.

[23]  M. Arisawa,et al.  Mutagenicity examination of several non-steroidal anti-inflammatory drugs in bacterial systems. , 1984, Mutation research.

[24]  M. Hall-Craggs,et al.  Interstitial nephritis, proteinuria, and renal failure caused by nonsteroidal anti-inflammatory drugs. Immunologic characterization of the inflammatory infiltrate. , 1984, The American journal of medicine.

[25]  R. Bernstein.  Ibuprofen-related meningitis in mixed connective tissue disease. , 1980, Annals of internal medicine.

[26]  P. Scorza Barcellona,et al.  The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats. , 1979, Toxicology and applied pharmacology.

[27]  H. J. Williams,et al.  Ibuprofen-associated aseptic meningitis in systemic lupus erythematosus. , 1979, The Western journal of medicine.

[28]  A. Arsenault,et al.  Gastrointestinal microbleeding after aspirin and naproxen , 1978, Clinical pharmacology and therapeutics.

[29]  J. Miller,et al.  Lymphopenia and hepatic toxicity with ibuprofen. , 1977, The Journal of pediatrics.

[30]  Erwin K. Kastrup,et al.  Drug facts and comparisons , 1977 .

[31]  G. Klein,et al.  [The effect of so-called basic therapeutics and symptomatically effective antirheumatic drugs on the enzymes of DNA synthesis and DNA repair]. , 1975, Acta medica Austriaca.

[32]  S. Adams,et al.  The metabolism of ibuprofen. , 1973, Xenobiotica; the fate of foreign compounds in biological systems.

[33]  J. Tjio,et al.  Chromosome preparations of bone marrow cells without prior in vitro culture or in vivo colchicine administration. , 1962, Stain technology.